Purplebricks fights off attempt to remove chairman

7

Rebel shareholders of estate agency Purplebricks (LON: PURP) have failed to unseat chairman Paul Pindar, who was supported by 71.7% of the votes. Management recognises the past underperformance and believes that progress will be evident by the time of the full year figures.

The rebel shareholders also failed to get Harry Hill appointed to the board of the AIM-quoted company at the general meeting, although this resolution was supported by 41.8% of the votes cast.

Purplebricks has reduced its cost base by £17m. The plan is to reach operational cash generation by April 2024.

In the six months to October 2022, revenues fell from £41.3m to £34.5m and the reported pre-tax loss increased from £12.9m to £14.6m. However, if exceptional costs are excluded the loss would have nearly trebled to £13.3m. That was despite much lower marketing spending.

Broker Zeus forecasts flat full year revenues of £70m and an underlying pre-tax loss of £19.8m. In 2023-24, a loss of £4.5m is anticipated following the full benefit of cost reductions.

Cash is expected to be £24.6m at the end of April 2023 and then rise to £27.4m at the end of April 2024, helped by deferred income not yet recognised in the income statement. NAV is expected to be down to £17.2m by that date.

At 9.65p, Purplebricks is valued at £30m.

AIM movers: Midateach Pharma revises funding terms and Star Phoenix has no auditor

2

Midatech Pharma (LON: MTPH) has revised the terms of the financing for the acquisition of TSX Venture Exchange quoted Bioasis Technologies Inc, a developer of treatments for rare and orphan diseases of the nervous system, and has decided to retain the AIM quotation. This is because of shareholder feedback. The share price recovered by 31% to 2.75p, which is 53% lower than one week ago. The purchase of Bioasis will be financed by the issue of 75.9 million shares and that valued the transaction at £4.4m when it was announced. The placement to raise $10m was going to be priced at $1/unit of ADSs and warrants. The final price will now be the lower of $1 and a 10% discount of the weighted average share price. The fundraising can be terminated if the price will be less than $0.90. The exercise price of the warrants has been increased from $1 to $1.10.

Diagnostics tests developer Abingdon Health (LON: ABDX) says it had cash of £4.4m on 19 December and should have £4.3m at the end of 2022. This should be enough cash for the next 12 months. The share price rose by 13.3% to 4.25p.

LBG Media (LON: LBG) has revised guidance for 2022, which shows a strong second half recovery. Full year revenues will be £63m. The rate of growth accelerated in the second half. However, this is still lower than the Zeus forecast. It has cut its pre-tax profit forecast by 18% to £13.5m. Net cash has been revised downwards from £46.1m to £31m. The 2023 pre-tax profit forecast has been cut from £20.1m to £17.2m. Even so, the share price has risen by 14% to 77.5p.

Information systems provider Journeo (JNEO) has won a £1.2m contract from Network Rail. This is to provide ScotRail with software and services. This will provide access to forward facing CCTV. This includes scanning and detecting objects on the track. The share price increased by 10.2% to 118.5p.

Shareholders of Star Phoenix (LON: STA) have voted against the removal of the auditor and the proposed replacement auditor, which had already started work. However, it is required to be appointed by shareholders, so accounts cannot be published. Another general meeting will be held next year. This means that trading in the shares will be suspended on 3 January. The share price slumped by 37% to 0.85p.

PCF Group (LON: PCF) has fallen by 28.6% to 0.5p ahead of the cancelation of the AIM quote tomorrow.

Angus Energy (LON: ANGS) is raising £7.1m at 1.65p a share. A further £1m worth of shares will pay deferred consideration to Forum Energy Services for Saltfleetby. The share price slipped by 15.3% to 1.575p. The cash will accelerate the field development and production at Saltfleetby. It will also finance the liability relating to a rolling hedge programme, which has been hit by production starting later than expected thereby requiring other hedging deals at higher prices. The completion of sidetrack drilling should be in January. A further compressor will double flow rate at Saltfleetby in January 2023. Angus Energy is also looking at other growth opportunities.

hVIVO (LON: HVO) says that phase 1 results for Imutex’s mosquito vaccine candidate have been published. It targets the saliva of the mosquito and hampers mosquito reproduction. The treatment was well tolerated and generated a “robust immune response”. hVIVO has a 49% stake in Imutex. The hVIVO share price has declined by 10.6% to 10.6p.

Aquis weekly movers: Hydrogen Utopia International moving to standard list

SuperSeed Capital Ltd (LON: WWW) is the best performer of the week following the announcement on Tuesday of managing director Mads Jensen’s purchase of 2,000 shares at 105p each. This appears to have happened on 8 December because it is the only trade since August. The share price improved by 10.8% to 102.5p. This is the highest the share price has ever been.

EPE Special Opportunities (LON: E.OP) rose by 3.33% to 155p, following the announcement of the November 2022 NAV of 241.17p a share. There were also 8,500 shares traded on the day.

Hydrogen Utopia International (LON: HUI) is planning a move to the standard list, which it believes will attract international investors. This should happen on 21 December. Hydrogen Utopia International has an exclusive, non-transferrable licence for the distributed modular gasification technology developed by AIM-quoted Powerhouse Energy (LON: PHE). The share price moved ahead by 3% to 12.875p.

One Health Group (LON: OHGR) reported interim revenues increased by 17% to £9.83m. Pre-tax profit was flat at £256,000. The NHS-funded medical procedures provider announced an interim dividend of 1.66p a share. The share price edged up 1.45% to 175p. One Health Group joined the Apex segment of the Aquis Stock Exchange on 24 November and raised £1.56m at 150p a share.

==========

Fallers

Education technology company Dev Clever (LON: DEV) plans to leave the standard list and that has hit the share price of Asimilar (LON: ASLR), which owns 72.3 million shares and 35 million warrants exercisable at 25p each. The Asimilar share price has slumped by 72.9% to 1.625p. Dev Clever, which is rebranding as Veative Group following a reverse takeover, shares were suspended at 30p in December 2021, and it believes that a lack of interest in smaller companies means it is not worth staying listed. The shares were suspended so that the company could publish a document relating to the reverse takeover. The company may return to the stockmarket in the future. The Dev Clever investment accounted for around two-thirds of the Asimilar net asset value of £30.9m at the end of March 2022 – based on a 27p share price. Asimilar is valued at £2.1m.

Aquis Stock Exchange owner Aquis Exchange (LON: AQX) announced the most popular stocks on the market will be available via IG Group’s IG.com platform. It was not stated which Aquis companies will be available via the platform. The Aquis Exchange share price fell by 8.24% to 390p.

S-Ventures (LON: SVEN) is acquiring the Juvela business, which manufactures gluten free products for £8m in cash, £1.5m deferred until September 2023, and five million shares. Shawbrook Bank is providing a £5.5m term loan and £500,000 revolving credit facility. This year Juvela is expected to generate revenues of £8.6m and should be profitable. The brand fits in well with the existing portfolio of brands and S-Ventures has a factory in Frankfurt. The share price fell back by 5.71% to 16.5p.

Altona Rare Earths (LON: ANR) had net assets of £1.05m at the end June 2022, including cash of £283,000. There was a £1.7m cash outflow from operations and capital investment. A maiden mineral resource estimate for the Monte Muambe real earths project should be available in the first quarter of 2023. The share price declined by 5.17% to 6.875p.

Invinity Energy Systems (LON: IES) is selling a 1.5MWh vanadium flow battery to partner Hyosung Heavy Industries and this system will be evaluated by Korea Electric Power Corporation. If the test is successful, then the battery system will be qualified for use in grid scale projects in South Korea. There will be an advanced payment in 2022 and the rest of the revenues will be in 2023. This is the latest deal in Asia. A $10m funding facility has been secured from Riverfort Global Opportunities and $2.5m has been drawn down to provide working capital. There were 2.7 million shares issued as part of the deal. The reference price for the initial advance is 44.9p a share and there are associated warrants exercisable at 67.35p. The share price had risen prior to the facility announcement but it ended the week down 4.4% to 43.5p.

Coinsilium Group Ltd (LON: COIN) expects to grow its advisory client base in areas, such as the Metaverse and gaming, It is also seeking to add to its investments. The share price dipped 2.78% to 1.75p.

Guanajuato Silver Company Ltd (LON: GSVR) is raising up to C$7.5m though an issue of units at C$0.425 each. The unit comprises one share and 0.5 of a warrant exercisable at C$0.60. The previous week the silver miner secured a $5m credit facility with Ocean Partners, which already provides a $5m facility. The cash will help to ramp up silver production and invest in processing facilities, as well as enabling additional exploration. The share price slipped by 1.85% to 26.5p.

AIM weekly movers: RUA Life Sciences bounces back

4

The RUA Life Sciences (LON: RUA) share price has recovered strongly following its interim results and chief executive Lachlan Smith bought 19,341 shares at 54.2p a share. Contract manufacturing revenues grew by two-thirds to £917,000 and the group total was £1.1m. The medical devices developer had net cash of £2.51m at the end of September 2022. Preparations are underway for clinical trial for large bore vascular grafts and a decision on which prototype aortic heart valve is better should be made soon. The share price has risen 43.9% to 47.5p.

Oriole Resources (LON: ORR) has published a maiden JORC resource for the Bibemi gold project in Cameroon. The pit-constrained resource is estimated to be 4.3 million tonnes grading 2.19/t gold equating to 305,000 ounces. There could be up to 148,000 of additional gold in other resource blocks. The directors have sacrificed a total of £8,000 from their salaries and have been issued 3.33 million shares at 0.1276p each. The share price increased by 40.9% to 0.155p during the week.

Steel structures supplier Billington (LON: BILN) will report a much better 2022 profit than anticipated. Forecasts have been raised by 50% to £5.9m and the 2023 pre-tax profit forecast increased by 56% to £7.55m. Business is being won at higher margins, while capital investment has boosted efficiency. The forecast dividend is 11p a share, up from the previously expected 8p a share. The hare price jumped 26.1% to 290p.

Blackbird (LON: BIRD) announced that its major partner is Belgium-based live video technology developer EVS Broadcast Equipment, which has already announced a $50m, ten-year deal with a US broadcaster. Blackbird completed the development and integration of its technology with EVS earlier this year. This deal incorporates Blackbird’s video editing technology and provides Blackbird with a per-seat user licence fee, as well as maintenance and support revenues. Similar deals are likely to be secured from EVS’s customer base. The share price recovered 26.1% to 14.5p.

Seed Innovations (LON: SEED) has risen consistently throughout the week. Interim results were followed by director buying. Chief executive Ed McDermott bought 3.425 million shares at 2.52p each and 850,000 shares at 2.69p each, while chairman Ian Burns purchased 300,000 shares at 2.57p each. The investment company has net assets of £16.7m, including £360,000 in cash, at the end of September 2022. That was after an unrealised loss on investments of £3.54m. Early in December, the conditional sale of investee company Leap Gaming to Seed Innovations’ partner was announced and that could generate €5.6m, plus the repayment of a €250,000 loan. The payments are expected to be over a two-year period. The investment and loan were valued at £6.07m (€7m). The shares rose by 25.8% to 2.8p, which values the company at £6m.

==========

Fallers

Trackwise Designs (LON: TWD) had already flagged that it would need more cash and subsequent fundraising is at a significant discount to the previous market price. The printed circuit technology supplier is raising £3.64m at 1p a share and a one-for-0.250054 open offer could raise up to £1.5m. Unsurprisingly, the share price has fallen sharply and is 89.6% lower at 1.325p. Hamilton Capital Partners is investing £1.21m in the fundraising. The funds should last until August, when it is likely that more cash will have to be raised. If production for new contracts gets going as expected there may be a more positive view of the company by then.

Midatech Pharma (LON: MTPH) is acquiring TSX Venture Exchange quoted Bioasis Technologies Inc and as part of the deal it will leave AIM but retain the Nasdaq listing. The purchase will be financed by the issue of 75.9 million shares and that valued the transaction at £4.4m when it was announced. There will be £8.2m raised through a fundraising via a share issue at 3.3p a share and the sale of units of ADSs and warrants at $1/ unit. Bioasis focuses on treatments for rare and orphan diseases of the nervous system. The lead product is a treatment for optic neuritis associated with MS. There are deals that generate milestone payments of up to $200m, but much of this cash could be paid many years in the future if ever. This will change the focus of the enlarged group from drug delivery to therapeutics. The group is changing its name to Biodexa Pharmaceuticals. The share price fell by 64.1% to 2.1p, which is well below the placing price.

There was a 97.88% shareholder vote in favour of Parsley Box (LON: MEAL) leaving AIM. The ready meals supplier has arranged a matched bargain facility for the shares through Asset Match. The share price had been declining, but it fell a further 63.1% to 1.55p.

Engage XR (LON: EXR) warns that the fourth quarter has been slower than expected and 2022 revenues will be below €4m, rather than the previously forecast €4.9m. The extended reality technology developer says customers have delayed contract decisions and this has put pressure on cash levels. Net cash should be €1.9m at the end of 2022. Cost savings are being considered to reduce the cash outflow. The share price slumped by 59.6% to 5.25p. In June 2021, £7.7m was raised at 16p a share.

CleanTech Company Heads towards Commercialisation of their Breakthrough Technology

Changeover Technologies, a CleanTech company, has developed an environmentally friendly and economical solution to reduce and recycle wastes, and is now heading towards the commercialisation of its revolutionary technology. 

It lets fine, small, tiny, even dust like waste particles, be transformed into pellets, sized and blended with additives or beneficial other wastes to suit the manufacturer’s specification. 

The platform technology can be applied to a variety of sectors from mining, industry to agriculture, and it’s plug and play modular concept lets it capture waste at key points within a company’s supply chain.  Changeover’s pellets produced from discarded fine particle wastes can be equivalent or better than the original raw material. 

The technology has been five years in development, and the breakthroughs made during the R&D stage attracted £5 million in venture capital investment, enabling the company to upscale their research, develop a live test site and laboratory, and then to patenting the pelleting technology. Today they have two patents approved and three pending, covering their binding formula and modular process components. 

Changeover’s technology is a green and commercial solution to clean-up and reduce wastes. It’s a win-win for producers and manufacturers, a green environmentally positive technology turning waste cost streams into high performing revenue streams. Turning waste into money. 

Silicon and Steel Industries 

Changeover’s initial niche target markets are reclaiming and recycling the discarded wastes from high purity carbon production. These high purity carbons are critical to the production of steel and silicon in advanced low CO2, high temperature Electric Arc Furnaces (EAF’s) and can experience 20% to 40% waste streams. 

This is a potential obtainable market of $450 million per annum which will continue to grow as traditional Iron Blast Furnaces are replaced with tomorrow’s greener combination Hydrogen & EAF technologies which will require fourfold supplies of high purity carbons. 

Silicon and steel are critical raw materials, essential for global sustainability in the production of electric vehicles, solar panels, wind turbines, electronics, lifesaving equipment, and other green technologies. 

Understanding Carbon

80% of global carbon is sourced from specialist metallurgical coals that form only 4% of global coal resources. Steel cannot be made from iron without the addition of high purity carbon within it, and silicon cannot be produced from silicon ore without silicon/carbon reactions.

Independent studies by Cranfield University have shown that by adopting Changeover’s technology to recycle these high-quality carbon wastes back into the circular economy, producers and manufacturers can reduce their overall scope 1&2 emissions, delivering greener raw materials from wastes. 

Coke, a pure form of commercial carbon, is derived from a finite natural resource, it is listed by the EU CRM association as one of the thirty Critical Raw Materials required for sustainable growth. Sustainability demands that it needs to be used efficiently and effectively. 

Independent Testing

Changeover Technologies’ economic and environmentally friendly solution has been independently tested by leading universities and institutes across the UK and Germany. They have confirmed: 

  • Reduction of damage to the ecosystem by 78%
  • Reduction of damage to human health by 81%
  • Reduction of damage to resources by 83%
  • Reduction of end-users’ Scope 1 and Scope 3 CO2 emissions within the supply chain.

Developments and Opportunities

Changeover Technologies is developing commercial and technical partnerships with British Steel and other high-profile companies in US, Europe, and Scandinavia, with commercial agreements planned for 2023 and first commercial units operating 2024.

The potential for this technology is enormous. Changeover is already involved in technical cooperation with a major Biocarbon group, as Changeover’s technology offers them the ability to reduce the Scope 2-Transport emissions by a quarter.

Within their R&D they have ongoing research into various wastes, with their “Blue Sky” AgriForm® technology, over 3 years in development and now ready to move forward with an industrial partner to take to commercial reality.

AgriForm® is pelletising technology combining electrical utility ash wastes with agricultural and other organic wastes, to produce PH balancing and water retaining pellets for soil enhancement in arid acid soils. This is an untapped potential $Billion market.

These are only a few of the opportunities that awaits Changeover Technologies within a variety of sectors. As they scale up and grow, many waste opportunities will present themselves, to be turned from discarded waste to quality pellets, from costs to revenues.

The future looks green and bright for Changeover Technologies. They are now crowdfunding to propel them to the next stage, commercialisation of their breakthrough technology. Their EBITDA is estimated to be $10 million, forecasting $100 million Exit by 2027.

Share price is £0.04

Pre-money valuation £11,475,552

Equity 4.46%

Housebuilders drag FTSE 100 lower after house price warning

The FTSE 100 was dragged lower by UK property companies on Friday after the Halifax warned UK housing prices could fall 8% next years.

The Halifax adds to a growing number of property experts and institutions expecting a reset in property prices as the cost of living crisis bites and higher interest rates put off buyers.

“Recent economic announcements and developments are beginning to be reflected in data. We are seeing a slowdown in the market and the number of mortgages approved for house purchase falling as well as a decline in new buyer enquiries,” said Tom Brown, Managing Director of Real Estate at Ingenious.

“There are a number of factors at play here including the escalating cost of living crises, but there will certainly be some very unwelcome additional mortgage costs for owner occupiers and investors throughout 2023 and beyond.”

Persimmon was down 3.3% while Taylor Wimpey gave up 3% and Barratt Developments shed 2.4%. Demonstrating concerns about the wider UK property market, Real Estate Investment Trusts Land Securities and British Land were weaker by 3.7% and 3% respectively.

Consumer headwinds

Halifax’s warning came on a day UK retail sales data also illustrated the pressures on the UK consumer. Data from the ONS showed retail sales declined 0.3% in November compared to 0.3% growth predicted by economists.

“The consumer is facing headwinds from falling real wage growth and inflation which has prompted the cost-of-living crisis by contributing to the squeeze on household budgets,” said Victoria Scholar, Head of Investment, interactive investor.

“Individuals are having to spend a larger proportion of their incomes on essentials like food and gas bills, which means there is less left over to spend on non-essential items with consumers cutting back on clothes and fuel spending.”

The soggy news on UK consumer spending and house prices culminated in a disappointing session for the FTSE 100 which was down 1.5% at the time of writing. Only one stock – Standard Chartered – was in positive territory at the time of writing.

After a strong recovery, can UK dividends continue to thrive in the year ahead?

Charles Luke, Investment Manager, Murray Income Trust PLC

  • UK dividends have seen a significant boost in 2022, but face challenges in the year ahead
  • Currency, sector strength and improved dividend cover should all help dividend growth
  • Higher quality companies should thrive in an environment of economic weakness

UK dividends have made a strong recovery since the pandemic, boosted by strong corporate earnings, a weak pound and high commodities prices. UK companies are set to pay an impressive £97.4bn in dividends in 2022. But can this strength last in 2023 in the face of high inflation, higher interest rates and a recession? 

The recovery in UK dividends has been stronger than many dared hope in the midst of Covid-19. The pandemic also helped strengthen the dividend position of many UK companies. Prior to the pandemic, some of the largest companies had been over-paying, leaving payouts looking extremely stretched relative to earnings. The pandemic allowed them to re-set those dividends at a lower level, improving dividend cover (the extent to which dividends are covered by earnings) and creating a stronger outlook. 

There have been other factors at work in the UK’s improving dividend picture. The commodities boom has helped oil and gas, and mining companies, which make up a significant proportion of the UK market. UK dividends have also benefited from a weaker currency because many UK companies have overseas revenues, which have been flattered by the conversion back into pounds. 

Many of these elements are still in place. High dividend cover gives companies flexibility, allowing them to pay growing dividends. There is still strong support for some of the UK’s key sectors: rising interest rates favours the banking sector, for example, while the energy transition looks to provide long-term support for the mining sector. The pound may have recovered somewhat against the US Dollar, but it remains near historic lows. 

However, recession now looks inescapable, which will make it more challenging for companies to deliver strong earnings, and may therefore put dividend growth at risk. While the outlook still appears strong for mining, oil and gas, or the banking sector, there are areas likely to be knocked by economic weakness – retail, for example. 

At this juncture, we believe quality is particularly important. Higher quality companies – those with a strong competitive advantage, robust balance sheet, experienced management teams and healthy ESG characteristics – are in the best possible position to pass on higher input costs and sustain their earnings through any economic weakness. Companies need to ensure that pricing power is resilient: because they are embedded in their customers’ work flows, have a strong brand, or are good at innovation. In contrast, companies with a lot of debt are always vulnerable in this type of environment. We see markets starting to differentiate clearly on these factors. 

Quality needs to be balanced with the need for a higher income stream. The best quality companies may not have the highest yields. At Murray Income Trust, we use option-writing to provide an additional income. This allows us to invest in high quality companies but with lower starting yields. As such, we can ‘trade’ some of the upside of an individual stock for a payment that is added to the income. It boosts the yield without adding to overall risk and allows us to invest in higher quality, but lower yielding companies. The trust also employs some gearing. 

There are other factors to consider in delivering a strong and robust dividend stream for investors. Diversification is vital in an unpredictable climate. The market can change very quickly and we need to avoid over-reliance on an individual sector. For example, we have 15% of the portfolio in overseas listed companies, which is helpful in terms of diversifying risk in individual sectors, such as pharmaceuticals, while also providing access to companies and industries that can’t be found in the UK market – elevator company Kone, for example, or luxury goods company LVMH. 

Robust research is also important. This is an environment likely to expose the smallest of weaknesses. At abrdn, we have a large global analyst team. This allows us to get under the skin of individual companies, understanding where the market may be misreading a company’s prospects and, importantly, allowing us to determine a fair price. Even the best company can be a bad investment if the price is too high. 

We can also support the income on the trust through revenue reserves. The investment trust structure allows us to reserve revenue in good times to support the pay-outs to shareholders in more difficult times. We used this facility modestly during the pandemic – precisely the type of rainy day we’d been saving for. 

Dividends are a vital part of Murray Income’s objectives. We understand that investors rely on the high and growing income we aim to provide. We’ve increased the dividend every year since 1973, qualifying the trust for ‘Dividend Hero’ status from the Association of Investment Companies. This is only achieved by being very careful about the quality of the companies in the portfolio, diversifying the yield and using the full powers of the investment trust structure. 

Five year dividend table (p)

Financial year20222021202020192018
Total dividend (p)36.0034.5034.2534.0033.25

Total return; NAV to NAV, net income reinvested, GBP. Share price total return is on a mid-to-mid basis. Dividend calculations are to reinvest as at the ex-dividend date. NAV returns based on NAVs with debt valued at fair value. Source: Aberdeen Asset Managers Limited, Lipper and Morningstar.

Important information

Risk factors you should consider prior to investing:

  • The value of investments, and the income from them, can go down as well as up and investors may get back less than the amount invested. 
  • Past performance is not a guide to future results. 
  • Investment in the Company may not be appropriate for investors who plan to withdraw their money within 5 years. 
  • The Company may borrow to finance further investment (gearing). The use of gearing is likely to lead to volatility in the Net Asset Value (NAV) meaning that any movement in the value of the company’s assets will result in a magnified movement in the NAV. 
  • The Company may accumulate investment positions which represent more than normal trading volumes which may make it difficult to realise investments and may lead to volatility in the market price of the Company’s shares. 
  • The Company may charge expenses to capital which may erode the capital value of the investment. 
  • Derivatives may be used, subject to restrictions set out for the Company, in order to manage risk and generate income. The market in derivatives can be volatile and there is a higher than average risk of loss. 
  • There is no guarantee that the market price of the Company’s shares will fully reflect their underlying Net Asset Value. 
  • As with all stock exchange investments the value of the Company’s shares purchased will immediately fall by the difference between the buying and selling prices, the bid-offer spread. If trading volumes fall, the bid-offer spread can widen. 
  • Certain trusts may seek to invest in higher yielding securities such as bonds, which are subject to credit risk, market price risk and interest rate risk. Unlike income from a single bond, the level of income from an investment trust is not fixed and may fluctuate. 
  • Yields are estimated figures and may fluctuate, there are no guarantees that future dividends will match or exceed historic dividends and certain investors may be subject to further tax on dividends.

Other important information:

Issued by abrdn Fund Managers Limited, registered in England and Wales (740118) at Bow Bells House, 1 Bread Street, London, EC4M 9HH. abrdn Investments Limited, registered in Scotland (No. 108419), 10 Queen’s Terrace, Aberdeen AB10 1XL. Both companies are authorised and regulated by the Financial Conduct Authority in the UK.

Find out more at www.murray-income.co.uk  or by registering for updates. You can also follow us on social media: Twitter and LinkedIn.

Reducing Industrial Carbon Emissions with Changeover Technologies

The UK Investor Magazine was delighted to welcome the Changeover Technologies team to the Podcast to explore their carbon-reducing technologies.

Changeover Technologies is reducing carbon emissions by providing industrial manufacturers the technology to reuse particle waste in their manufacturing process.

Changeover Technologies is tackling the problem of up to 40% carbon waste by providing plug-and-play processing units to customers to produce pellet feedstock.

The company is currently raising funds on Crowdcube.

AIM movers: Time Finance profit recovery and proposed Dev Clever delisting hits Asimilar

11

Small business finance provider Time Finance (LON: TIME) revenues are increasing and this is falling through to profit. In the six months to November 2022, revenues are 27% ahead at £13.2m and pre-tax profit improved from £1.2m to £2m. This is well on the way to the full year forecast of £2.8m. The gross lending book is £152.7m. The share price recovered 8.95% to 20.7p.

Zanaga Iron Ore Company (LON: ZIOC) has completed the acquisition of a controlling shareholding in the Zanaga iron ore project from Glencore Projects in return for the issue of a 48.26% stake in the company. Glencore has appointed Peter Hill and Denis Weinstein to the board. Glencore has exclusive marketing rights for the iron ore produced at the mine. The Zanaga Iron Ore share price rose 8.21% to 5.275p. Zanaga Iron Ore is in the top 40 AIM companies in terms of this year’s share price performance.

Business disposals and tax adviser K3 Capital (LON: K3C) is recommending a 350p a share cash bid from a vehicle controlled by affiliates of Sun European Partners. This values K3 Capital at £272m. The share price had already risen when the bid talks were announced, and it is 7.56% higher on the day at 341.5p. K3 Capital joined AIM in 2017 at 95p a share.

Redx Pharma (LON: REDX) has entered a clinical trial collaboration with Merck for the supply of Keytruda to be used in the combination arm of Redx’s PORCUPINE2 phase 2 clinical study evaluating RXC004 as a potential treatment for patients with biliary cancer. The share price rose 6.19% to 60p.

Education technology company Dev Clever (LON: DEV) plans to seek to leave the standard list and that has hit the share price of Asimilar (LON: ASLR), which owns 72.3 million shares and 35 million warrants exercisable at 25p each. The Asimilar share price has slumped by 58.1% to 1.625p. Dev Clever, which is rebranding as Veative Group, shares were suspended at 30p in December 2021, and it believes that a lack of interest in smaller companies means it is not worth staying listed. It may return to the market in the future. The Dev Clever investment accounted for around two-thirds of the Asimilar net asset value of £30.9m at the end of March 2022 – based on a 27p share price. Asimilar is valued at around £2m.

Broker and wealth manager WH Ireland (LON: WHI) revenues declined from £17m to £14.3m and it moved from profit to an underlying loss of £900,000. Both divisions lost money and market conditions are still challenging. However, the full year loss should be lower. The share price slipped 16.4% to 23p. This is the lowest the share price has been since 2003.

Restaurants operator Fulham Shore (LON: FUL) increased interim revenues by 26% to £49.9m and it has opened four sites since September. A range of cook-at-home Franco Manca pizzas have been launched. Management is cautious about the future even though trading in the first two months of the second half was 12% ahead. Costs are increasing and transport problem are having a negative effect. The share price declined by 15.6% to 9.5p.

North Sea oil and gas project developer Orcadian Energy (LON: ORCA) is in discussions with a preferred FPSO provider for the Pilot field but it is also exploring other concepts that could reduce capex. Pro forma cash is £1.2m. Farmout discussions could start after further progress has been made in field engineering development. WH Ireland has a fair value estimate of 259.2p a share. The share price fell 14.3% to 16.5p. The July 2021 placing price was 40p and the most recent placing was at 35p.

New AIM admission: Smarttech247

Cyber security services provider Smarttech 247 has been planning to join AIM for more than one year and it has finally arrived. The cash raised and conversion of loan notes mean that there is a strong balance sheet to propel growth.
There will be €1m spent on new products and moving into new geographical markets. Another €200,000 will be spent on technology development. That leaves plenty of cash for working capital.
The share price ended the first day of trading at 30.5p (29.5p/31.5p) and more than 23,000 shares were traded via six bargains. Nearly 90% of the shares are tightly held so the li...